Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Anvil 400 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Anvil 400

Approved

STANDARD

Anvil 400

ATC Healthcare International Corporation🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: bcfe897bea87eccb
Company: ATC Healthcare International Corporation
Type: Standard

Approval Details

Approval Id: bcfe897bea87eccb
Drug Approval Philippines Name: Anvil 400
Product Name: Anvil 400
Registration Number: DRP-7503
Brand Name: Anvil 400
Generic Name: Ibuprofen
Dosage Form: Soft Gelatin Capsule
Dosage Strength: 400 mg
Manufacturer: ATC Healthcare International Corporation
Trader: ATC Health Care International Corp.
Distributor: ATC Health Care International Corp.
Issuance Date: 27 October 2022
Expiry Date: 23 November 2027
Pharmacologic Category: Nonsteroidal Anti-Inflammatory Drug
Classification: Over-The-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

bcfe897bea87eccb

Type

Standard

Back to Philippines FDA Approvals